594 related articles for article (PubMed ID: 25446925)
1. Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain.
Bagüés A; Martín MI; Sánchez-Robles EM
Eur J Pharmacol; 2014 Dec; 745():69-75. PubMed ID: 25446925
[TBL] [Abstract][Full Text] [Related]
2. Delta-9-tetrahydrocannabinol decreases masticatory muscle sensitization in female rats through peripheral cannabinoid receptor activation.
Wong H; Hossain S; Cairns BE
Eur J Pain; 2017 Nov; 21(10):1732-1742. PubMed ID: 28722246
[TBL] [Abstract][Full Text] [Related]
3. The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors.
Dani M; Guindon J; Lambert C; Beaulieu P
Eur J Pharmacol; 2007 Nov; 573(1-3):214-5. PubMed ID: 17651722
[TBL] [Abstract][Full Text] [Related]
4. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.
Cox ML; Haller VL; Welch SP
Eur J Pharmacol; 2007 Sep; 570(1-3):50-6. PubMed ID: 17588560
[TBL] [Abstract][Full Text] [Related]
5. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
Calik MW; Carley DW
Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
Craft RM; Wakley AA; Tsutsui KT; Laggart JD
J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
[TBL] [Abstract][Full Text] [Related]
7. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
Romero TR; Resende LC; Guzzo LS; Duarte ID
Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
[TBL] [Abstract][Full Text] [Related]
8. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG
Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids and muscular pain. Effectiveness of the local administration in rat.
Sánchez Robles EM; Bagües Arias A; Martín Fontelles MI
Eur J Pain; 2012 Sep; 16(8):1116-27. PubMed ID: 22354705
[TBL] [Abstract][Full Text] [Related]
10. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
Haller VL; Cichewicz DL; Welch SP
Eur J Pharmacol; 2006 Sep; 546(1-3):60-8. PubMed ID: 16919265
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells.
Rao GK; Zhang W; Kaminski NE
J Leukoc Biol; 2004 May; 75(5):884-92. PubMed ID: 14966196
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats.
Calik MW; Carley DW
PLoS One; 2014; 9(10):e111412. PubMed ID: 25350456
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.
Silva NR; Gomes FV; Fonseca MD; Mechoulam R; Breuer A; Cunha TM; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):369-377. PubMed ID: 28720466
[TBL] [Abstract][Full Text] [Related]
14. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Romero TR; Pacheco Dda F; Duarte ID
Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid CB
Weresa J; Pędzińska-Betiuk A; Kossakowski R; Malinowska B
Pharmacol Rep; 2019 Feb; 71(1):82-89. PubMed ID: 30500553
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid system involves in the analgesic effect of protocatechuic acid.
Dikmen DY; Okcay Y; Arslan R; Bektas N
Daru; 2019 Dec; 27(2):605-612. PubMed ID: 31325037
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.
Booker L; Naidu PS; Razdan RK; Mahadevan A; Lichtman AH
Drug Alcohol Depend; 2009 Nov; 105(1-2):42-7. PubMed ID: 19679411
[TBL] [Abstract][Full Text] [Related]
18. Effect of cannabinoids upon the uptake of folic acid by BeWo cells.
Araújo JR; Gonçalves P; Martel F
Pharmacology; 2009; 83(3):170-6. PubMed ID: 19145103
[TBL] [Abstract][Full Text] [Related]
19. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to cannabinoid receptors activation in mice.
Veloso CC; Ferreira RCM; Rodrigues VG; Duarte LP; Klein A; Duarte ID; Romero TRL; Perez AC
Inflammopharmacology; 2018 Feb; 26(1):227-233. PubMed ID: 28889355
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive effects of central administration of the endogenous cannabinoid receptor type 1 agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-terminally extended hemopressin peptide.
Han ZL; Fang Q; Wang ZL; Li XH; Li N; Chang XM; Pan JX; Tang HZ; Wang R
J Pharmacol Exp Ther; 2014 Feb; 348(2):316-23. PubMed ID: 24307201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
